[HTML][HTML] Histological validation of cardiovascular magnetic resonance T1 mapping markers of myocardial fibrosis in paediatric heart transplant recipients

S Ide, E Riesenkampff, DA Chiasson… - Journal of …, 2016 - Elsevier
Background Adverse fibrotic remodeling is detrimental to myocardial health and a reliable
method for monitoring the development of fibrotic remodeling may be desirable during the …

[HTML][HTML] Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience

P Kellman, JR Wilson, H Xue, WP Bandettini… - Journal of …, 2012 - Elsevier
Background Diffuse myocardial fibrosis, and to a lesser extent global myocardial edema, are
important processes in heart disease which are difficult to assess or quantify with …

CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF

MYM Su, LY Lin, YHE Tseng, CC Chang, CK Wu… - JACC: Cardiovascular …, 2014 - jacc.org
Objectives: The purpose of this study was to investigate diffuse myocardial fibrosis in
patients with systolic heart failure (SHF) and in patients with heart failure with preserved …

Cardiovascular magnetic resonance imaging to assess myocardial fibrosis in valvular heart disease

T Podlesnikar, V Delgado, JJ Bax - The international journal of …, 2018 - Springer
The left ventricular (LV) remodeling process associated with significant valvular heart
disease (VHD) is characterized by an increase of myocardial interstitial space with …

Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR

G Moravsky, E Ofek, H Rakowski, J Butany… - JACC: Cardiovascular …, 2013 - jacc.org
Objectives: In this study we sought to explore the relationship between cardiac magnetic
resonance (CMR) with late gadolinium enhancement (LGE) and histopathological …

Myocardial fibrosis: why image, how to image and clinical implications

R Bing, MR Dweck - Heart, 2019 - heart.bmj.com
The current era has seen major advances in myocardial imaging. We are now able to
assess cardiac anatomy, function, tissue composition and disease activity across a wide …

[HTML][HTML] Extracellular volume quantification in isolated hypertension-changes at the detectable limits?

TA Treibel, F Zemrak, DM Sado, SM Banypersad… - Journal of …, 2015 - Elsevier
Background Diffuse myocardial fibrosis (DMF) is important in cardiovascular disease,
however until recently could only be assessed by invasive biopsy. We hypothesised that …

Reappraising myocardial fibrosis in severe aortic stenosis: an invasive and non-invasive study in 133 patients

TA Treibel, B López, A González… - European heart …, 2018 - academic.oup.com
Aims To investigate myocardial fibrosis (MF) in a large series of severe aortic stenosis (AS)
patients using invasive biopsy and non-invasive imaging. Methods and results One hundred …

Multimodality imaging assessment of myocardial fibrosis

S Gupta, Y Ge, A Singh, C Gräni, RY Kwong - Cardiovascular Imaging, 2021 - jacc.org
Myocardial fibrosis, seen in ischemic and nonischemic cardiomyopathies, is associated with
adverse cardiac outcomes. Noninvasive imaging plays a key role in early identification and …

Novel imaging techniques for diffuse myocardial fibrosis

DM Sado, AS Flett, JC Moon - Future Cardiology, 2011 - Taylor & Francis
Diffuse myocardial fibrosis (DMF) is an important marker in many cardiac diseases, but its
utility has been limited by the need for biopsy for its assessment. An accurate noninvasive …